HSA — authorised 17 March 2015
- Marketing authorisation holder: RTRX
- Status: likely_approved
HSA authorised Cholbam on 17 March 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 17 March 2015.
RTRX holds the Singaporean marketing authorisation.